ACHV
Healthcare BiotechnologyAchieve Life Sciences, Inc.
$6.96
-0.38 -5.13% today Live
Price History
Not enough data
| Date | Price |
|---|---|
| Oct 5, 2026, live at 2:21 PM ET | 6.96 |
Key Stats
Market Cap
717.59M
Avg Volume
1.47M
EPS
-$1.69
52W High
$8.64
52W Low
$2.62
Div. Yield
0.0%
Analyst Ratings
Buy3
Str Buy
9
Buy
0
Hold
0
Sell
0
Str Sell
Valuation
Forward P/E
-10.67
P/B Ratio
-48.67
EV/EBITDA
-9.86
PEG Ratio
17.68
Margins
Gross Margin 0.0%
Operating Margin 0.0%
Net Margin 0.0%
EBITDA Margin 0.0%
Growth & Returns
Return on Equity
(845.0%)
Return on Assets
(29.2%)
Liquidity & Leverage
Current Ratio
0.95
Quick Ratio
0.95
Total Cash
187.30M
Total Debt
14.95M
About
Achieve Life Sciences, Inc., a late-stage pharmaceutical company, develops and commercializes cytisinicline for nicotine independence in Canada, the United States, and the United Kingdom. The company offers cytisinicline, a naturally occurring alkaloid that interacts with nicotine receptors in the brain that reduces the severity of nicotine withdrawal symptoms. It has license and supply agreements with Sopharma AD and University of Bristol. Achieve Life Sciences, Inc., is headquartered in Bothell, Washington.
www.achievelifesciences.com